# [14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects

> **NCT05754411** · PHASE1 · COMPLETED · sponsor: **Zhejiang ACEA Pharmaceutical Co. Ltd.** · enrollment: 6 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** [14C]STI-1558

## Key facts

- **NCT ID:** NCT05754411
- **Lead sponsor:** Zhejiang ACEA Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2023-06-22
- **Final completion:** 2023-11-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754411, "[14C] Study on Mass Balance and Biotransformation of STI-1558 in Healthy Chinese Adult Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05754411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*